-
Probenecid: A Causal Guide to Transporter Assays
2026-09-08
Probenecid research extends beyond MRP inhibition: this guide shows how to separate transporter blockade, pannexin-1 effects, and injury-state biology in leukemia and cerebral ischemia/reperfusion assays. It also translates a classic neurological methylation review into practical decisions about controls, endpoints, and mechanistic confidence.
-
Polygodial for Reliable TRPA1 and Viability Assays
2026-09-08
This scenario-based guide shows how Polygodial SKU B7311 can support controlled TRPA1 ion-channel experiments while helping researchers separate pathway activation from nonspecific effects in cell viability and inflammatory readouts. It covers compatibility, handling, protocol design, interpretation, and practical supplier selection using product information and peer-reviewed evidence.
-
IGF2BP3–MCM5–Notch Drives LUAD Metastasis
2026-09-07
This study identifies an m6A-dependent IGF2BP3/MCM5/Notch pathway that promotes partial epithelial–mesenchymal transition and metastatic plasticity in lung adenocarcinoma. Its combination of clinical correlation, RNA-stability analysis, mechanistic rescue experiments, and metastasis models provides a framework for studying how RNA modification controls tumor-cell state transitions.
-
Capsaicin, Autophagy, and BMSC Protection
2026-09-07
The reference study shows that capsaicin protects rat bone marrow stromal cells from hydrogen peroxide-induced oxidative stress while preserving viability and osteogenic differentiation. Its proposed mechanism links TRPV1-dependent calcium influx with increased autophagy and reduced PI3K/AKT/mTOR phosphorylation, providing a mechanistic framework for studying BMSC dysfunction in osteoporosis.
-
Prestained Protein Marker for RA Neuron Studies
2026-09-05
Use a triple-color, EDTA-free ladder to connect gel separation, transfer control, and phospho-STAT3 interpretation in rheumatoid arthritis sensory-neuron assays. The workflow combines rapid visual landmarks with compatibility for Phosbind gels and fluorescent membrane imaging.
-
Adipose-Neural Signaling in Cardiac Arrhythmia
2026-09-04
Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin–NPY–Y1R pathway. The study connects this signaling cascade to NCX and CaMKII activity, arrhythmic phenotypes, and clinical measurements in patients with atrial fibrillation, while identifying important receptor-specific limits for translating the findings.
-
Tranexamic Acid: From Fibrinolysis to Clot-Stable Design
2026-09-04
Tranexamic Acid is more than a clot-preserving reagent: it is a mechanistically defined tool for connecting plasmin biology, fibrinolysis research, and next-generation hemostatic materials. This article translates the evidence into experimental and translational strategy.
-
PP 1: A Translational Map for Src Kinase Research
2026-09-03
A thought-leadership analysis of PP 1 as a mechanistic probe for Src-family signaling, T-cell biology, RET-driven transformation, and resistance research in HER2-positive breast cancer.
-
Actinomycin D Workflows for Cancer Research
2026-09-03
Actinomycin D enables controlled transcription shutoff, mRNA decay measurements, and mechanistic follow-up of cancer phenotypes. This workflow-oriented guide connects ActD treatment to the circRNA–miR-330-5p–MCT4 axis in bladder cancer while emphasizing dose selection, assay controls, and troubleshooting.
-
Protease Inhibitor Cocktail: Metabolic Lysate Workflows
2026-09-02
Learn how an EDTA-free protease inhibitor supports reproducible liver, adipose, cell-lysate, Western blot, co-IP, and kinase workflows without deliberately chelating divalent cations. The guide translates findings from a diet-derived AGE mouse study into practical sampling, extraction, assay-selection, and troubleshooting decisions.
-
Tigecycline and the Next Era of MDR Translation
2026-09-02
Tigecycline offers translational researchers more than a broad-spectrum antibiotic: it is a mechanistically distinct probe for studying resistant pathogens, tissue exposure, and the gap between mobile resistance genes and functional antimicrobial susceptibility.
-
Guanabenz Acetate: Designing Better Stress Assays
2026-09-01
Guanabenz Acetate is an α2-adrenergic receptor agonist that can help dissect how adrenergic GPCR signaling intersects with cellular stress assays. This article separates established receptor pharmacology from testable hypotheses inspired by SARS-CoV-2 GADD34 research.
-
GDC-0994: ERK1/2 Inhibitor Workflows
2026-09-01
GDC-0994 is a selective ERK1/2 inhibitor for testing pathway dependence in BRAF- and RAS-driven cancer models. Its use also extends to mechanistic zebrafish studies of estrogen-associated cholestasis, where phospho-ERK rescue can connect molecular signaling to functional liver phenotypes.
-
Pregnenolone Carbonitrile in PXR Assay Design
2026-08-31
Pregnenolone Carbonitrile is a rodent PXR agonist that can connect CYP3A induction, disease-state pharmacokinetics, and antifibrotic assay design. This article presents a disease-aware framework for selecting controls and interpreting hepatic results.
-
Ibrutinib (PCI-32765): Assay Logic for BTK
2026-08-31
Ibrutinib (PCI-32765) enables mechanistic studies of BTK-dependent B-cell signaling, but its greatest value comes from pairing covalent target inhibition with genotype-aware assay design. This guide connects B-cell experiments with lessons from ATRX-stratified inhibitor screening while clearly separating established evidence from exploratory use.